Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.6 (
RNA polymerase
)
34,946
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The transcription elongation factor TFIIS is encoded by a three member gene family in vertebrates. Here we show that one member of this family,
TCEA3
, is upregulated during skeletal muscle differentiation and acts to promote gene activation by the myogenic regulatory family of transcription factors, which includes MyoD and myogenin. We show that myogenin is a direct regulator of Tcea3. Myogenin binds to the Tcea3 promoter and is required to recruit
RNA polymerase II
.
TCEA3
can bind to both myogenin and MyoD and is co-recruited with the MRFs to promoters dependent on the MRFs. Depletion of myogenin inhibits the recruitment of
TCEA3
, suggesting that the interaction of
TCEA3
with the MRFs serves to aid in recruitment to target promoters. Like TFIIS, we show that
TCEA3
interacts with
RNA polymerase II
.
TCEA3
travels with the elongating
RNA polymerase II
in the coding region of genes and depletions of
TCEA3
inhibit the recruitment of
RNA polymerase II
to promoters. In proliferating cells,
TCEA3
expressed at low levels and is present in both the nucleus and cytoplasm. However, upon differentiation,
TCEA3
is upregulated and transported exclusively to the nucleus. Thus, our data show that
TCEA3
is a required co-factor for MRF driven gene expression during myogenesis.
...
PMID:The transcription elongation factor TCEA3 promotes the activity of the myogenic regulatory factors. 3115 46